Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Patterson

Showing results (1111-1120 of 1,157) with videos related to

Pageof 116
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2012
Phase I clinical and pharmacokinetic evaluation of the vascular-disrupting agent OXi4503 in patients with advanced solid tumorsDan M Patterson, Martin Zweifel, Mark R Middleton, et al.
Radiation Research|February 12, 2021
Establishing Pediatric Mouse Models of the Hematopoietic Acute Radiation Syndrome and the Delayed Effects of Acute Radiation ExposureAndrea M Patterson, Rajendran Sellamuthu, P Artur Plett, et al.
Nature Communications|December 6, 2019
Heterogeneity and dynamics of active Kras-induced dysplastic lineages from mouse corpus stomachJimin Min, Paige N Vega, Amy C Engevik, et al.
The Journal of Bone and Joint Surgery. American Volume|February 24, 2001
A prospective evaluation of the clinical utility of the lower-extremity injury-severity scoresM J Bosse, E J MacKenzie, J F Kellam, et al.
Diabetes, Obesity & Metabolism|October 6, 2010
Cerebellin1 is a novel orexigenic peptideJ V Gardiner, K E Beale, D Roy, et al.
British Journal of Pharmacology|October 1, 2010
Alarin stimulates food intake and gonadotrophin release in male ratsC K Boughton, M Patterson, G A Bewick, et al.
The Journal of Biological Chemistry|March 14, 2008
A new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cellsChengjian Mao, Nicole M Patterson, Milu T Cherian, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2006
Synthesis and structure-activity studies of novel benzocycloheptanone oxazolidinone antibacterial agentsJ V N Vara Prasad, Frederick E Boyer, Lou Chupak, et al.
Frontiers in Oncology|July 28, 2025
ACTivity as medicine In Oncology for Head and Neck (ACTIOHN): a feasibility study investigating a patient-centred approach to exercise for head and neck cancer patientsJoanne M Patterson, Mary G Cherry, Andrew Levy, et al.
International Journal of Circumpolar Health|May 8, 2020
The implementation of rifapentine and isoniazid (3HP) in two remote Arctic communities with a predominantly Inuit population, the Taima TB 3HP studyG G Alvarez, D Van Dyk, R Mallick, et al.
Pageof 116

Showing results (1111-1120 of 1,157) with videos related to

Sort By:
Pageof 116
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2012
Phase I clinical and pharmacokinetic evaluation of the vascular-disrupting agent OXi4503 in patients with advanced solid tumorsDan M Patterson, Martin Zweifel, Mark R Middleton, et al.
Radiation Research|February 12, 2021
Establishing Pediatric Mouse Models of the Hematopoietic Acute Radiation Syndrome and the Delayed Effects of Acute Radiation ExposureAndrea M Patterson, Rajendran Sellamuthu, P Artur Plett, et al.
Nature Communications|December 6, 2019
Heterogeneity and dynamics of active Kras-induced dysplastic lineages from mouse corpus stomachJimin Min, Paige N Vega, Amy C Engevik, et al.
The Journal of Bone and Joint Surgery. American Volume|February 24, 2001
A prospective evaluation of the clinical utility of the lower-extremity injury-severity scoresM J Bosse, E J MacKenzie, J F Kellam, et al.
Diabetes, Obesity & Metabolism|October 6, 2010
Cerebellin1 is a novel orexigenic peptideJ V Gardiner, K E Beale, D Roy, et al.
British Journal of Pharmacology|October 1, 2010
Alarin stimulates food intake and gonadotrophin release in male ratsC K Boughton, M Patterson, G A Bewick, et al.
The Journal of Biological Chemistry|March 14, 2008
A new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cellsChengjian Mao, Nicole M Patterson, Milu T Cherian, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2006
Synthesis and structure-activity studies of novel benzocycloheptanone oxazolidinone antibacterial agentsJ V N Vara Prasad, Frederick E Boyer, Lou Chupak, et al.
Frontiers in Oncology|July 28, 2025
ACTivity as medicine In Oncology for Head and Neck (ACTIOHN): a feasibility study investigating a patient-centred approach to exercise for head and neck cancer patientsJoanne M Patterson, Mary G Cherry, Andrew Levy, et al.
International Journal of Circumpolar Health|May 8, 2020
The implementation of rifapentine and isoniazid (3HP) in two remote Arctic communities with a predominantly Inuit population, the Taima TB 3HP studyG G Alvarez, D Van Dyk, R Mallick, et al.
Pageof 116